Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Update: Common anticholinergic meds seen to increase dementia risk

________________

Dear read­er,

It’s time for Sharp­Brains e‑newsletter dis­cussing the lat­est research and inno­va­tions to help pro­mote brain health, open­ing in this occa­sion with a large and wor­ry­ing study track­ing the long-term neur­al impact of com­mon­ly pre­scribed med­ica­tions.

New brain research:

New brain technology:

New brain thinking:

 

Last but not least, here is a fun brain teas­er for the week­end.  What do you see?

 

Have a great month of July,

 

The Sharp­Brains Team

First, do no harm? Common anticholinergic meds seen to increase dementia risk

_________

Com­mon­ly Pre­scribed Meds Could Raise Demen­tia Risk (Web­MD):

Doc­tors often pre­scribe anti­cholin­er­gic drugs for a vari­ety of ills. But a new study sug­gests they may increase the risk of demen­tia in old­er patients.

These med­i­cines include every­thing from Benadryl (diphen­hy­dramine) to cer­tain antipsy­chotics and Parkin­son’s meds. They’re used to treat a wide range of oth­er con­di­tions, includ­ing depres­sion, chron­ic obstruc­tive pul­monary dis­ease, over­ac­tive blad­der, aller­gies, and gas­troin­testi­nal dis­or­ders.

Anti­cholin­er­gic drugs help con­tract and relax mus­cles, and work by block­ing acetyl­choline, a chem­i­cal that trans­mits mes­sages in the ner­vous sys­tem … the new British study found that peo­ple aged 55 and old­er who took strong anti­cholin­er­gic med­ica­tions dai­ly for three years or more had a 50% increased risk of demen­tia Read the rest of this entry »

Study: Common medication treatments for PTSD can increase the risk of developing dementia

—–

Drugs for PTSD linked to increased risk of demen­tia (The Phar­ma­ceu­ti­cal Jour­nal):

Cer­tain psy­chotrop­ic drugs used to treat post-trau­mat­ic stress dis­or­der (PTSD) increase the risk of devel­op­ing demen­tia, includ­ing in patients who do not have PTSD but take the drugs for oth­er con­di­tions, study results pub­lished in the Jour­nal of the Amer­i­can Geri­atrics Soci­ety Read the rest of this entry »

New studies reinforce Education and Cognitive Reserve –instead of drugs targeting beta amyloid– as most promising avenue to prolong cognitive health and reduce dementia risk

dementia-progressionDemen­tia Risk Declines, And Edu­ca­tion May Be One Rea­son Why (NPR):

Some encour­ag­ing news in the bat­tle against Alzheimer’s dis­ease and oth­er forms of demen­tia: The rate at which old­er Amer­i­cans are get­ting these con­di­tions is declin­ing. That’s accord­ing to Read the rest of this entry »

Update: Well-targeted brain training might significantly reduce dementia risk

-- M GLASSER, D VAN ESSEN/WASHINGTON UNIVERSITY

– M GLASSER, D VAN ESSEN/WASHINGTON UNIVERSITY

Time for a new edi­tion of Sharp­Brains’ e‑newsletter. Hap­py read­ing!

New brain research

New tools for brain health and performance

New thinking

Final­ly, a quick reminder: Ear­ly-bird rates to par­tic­i­pate in the 2016 Sharp­Brains Vir­tu­al Sum­mit (Decem­ber 6–8th) end on Sep­tem­ber 15th. Please con­sid­er reg­is­ter­ing ear­ly to ben­e­fit from those dis­count­ed rates and to help us shape the Sum­mit Agen­da! Learn More and Reg­is­ter HERE.

Have a great month of August,

The Sharp­Brains Team

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

twitter_logo_header
RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.